As co-author of the European Headache Federation (EHF) guideline on the use of anti-CGRP monoclonal antibodies (mAbs) for migraine prevention, Lars Bendtsen presented an overview of the scientific basis for the recommendations.

1. Sacco et al. J Headache Pain 2019.